SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001047469-99-030602
Filing Date
1999-08-10
Accepted
1999-08-10 00:00:00
Documents
1
Group Members
BIOTECHNOLOGY VALUE FUND L PBVF INC.BVF PARTNERS L.P.

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D/A, COVER SC 13D/A 22547
  Complete submission text file 0001047469-99-030602.txt   24682
Mailing Address 227 W MONROE STREET, SUITE 4800 227 W MONROE STREET, SUITE 4800 CHICAGO IL 60606
Business Address 227 W MONROE STREET, SUITE 4800 227 W MONROE STREET, SUITE 4800 CHICAGO IL 60606
BIOTECHNOLOGY VALUE FUND L P (Filed by) CIK: 0000918923 (see all company filings)

IRS No.: 363924731 | State of Incorp.: DE
SIC: 6282 Investment Advice

Mailing Address 505 COAST BLVD SOUTH SUITE 300 LA JOLLA CA 92037
Business Address 505 COAST BLVD SOUTH STE 300 LA JOLLA CA 92037 6194525892
SIBIA NEUROSCIENCES INC (Subject) CIK: 0001011065 (see all company filings)

IRS No.: 953616229 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-48087 | Film No.: 99682343
SIC: 2834 Pharmaceutical Preparations